SlideShare ist ein Scribd-Unternehmen logo
1 von 3
Downloaden Sie, um offline zu lesen
Aetna Inc.
The following is a summary of certain 2005 projected financial information and metrics provided on Aetna’s investor
conference call on July 28, 2005. This information is provided for reference only, and has not been updated. You should
consider the information to speak only as of its date of original publication. Aetna does not assume any responsibility to
update the information to reflect subsequent events. Please also refer to the Cautionary Statement below for additional
information regarding important risk factors that may affect the forward looking and other information.

You should read this information in conjunction with Aetna’s earnings press release issued July 28, 2005 and should
review the replay of the related investor call in full, since the press release provides further discussion of the Company’s
results, and the investor call provides important context for the forward looking information.

                                                                                              Aetna Inc.
                                                                                         2005 Guidance as of
                                                                                              7/28/2005
                                                                                     (Full year unless otherwise noted)
Aetna Inc.
 Operating Earnings (1)                                                                 $4.52 - $4.57 per share
                                                                                        $1,375 - $1,390 million
                                                                                        3Q05 - $1.16 per share

 Revenue (excluding net realized capital gains or losses) (2)                        Greater than or equal to 13%

 Total Operating Expense Ratio (3)                                                        Slightly above 19%

                                                                                         > Operating Earnings
 Operating Cash Flow

 Pretax Operating Margin (4)                                                                      ≈ 10%

                                                                                                  ≈ 36%
 Effective Tax Rate

                                                                                             ≈ $80 million
 Corporate Interest Expense
Information by Segment:
Health Care
 Operating Earnings (1)                                                                 $1,305 - $1,320 million

                                                                                   Growth 1,000k – 1,075k members
 Medical Membership

 Commercial Risk Cost Trend (5)                                                               8.0% - 8.5%

 Commercial Risk MCR (5) (6)                                                                      < 80%

 Commercial Risk Premium Yield (5)                                                      In line with cost trend

Group Insurance
 Operating Earnings (1)                                                                      ≈ $130 million

LCP
 Operating Earnings (1)                                                                      ≈ $20 million



Note: The symbol “≈” means “approximately”.



July 28, 2005                                               Aetna Inc.                                                    Page 1 of 3
Aetna Inc.
Footnotes
(1) Projected 2005 operating earnings and projected 2005 operating earnings per share exclude the following after tax net realized capital gains
(losses) reported by the Company for the six months ended June 30, 2005: Aetna Inc. $6.6 million; Health Care $3.8 million; Group Insurance
$3.3 million and Large Case Pensions $(0.5) million and also exclude any future net realized capital gains or losses from income from
continuing operations. The Company is not able to project the amount of future net realized capital gains or losses and cannot therefore
reconcile projected 2005 operating earnings to projected income from continuing operations or reconcile to a projected change in income from
continuing operations. Although the excluded items may recur, management believes that operating earnings and operating earnings per share
provide a useful comparison of its underlying business performance from period to period. Net realized capital gains and losses arise from
various types of transactions in the course of managing a portfolio of assets that support the payment of liabilities, but these transactions do not
directly relate to the underwriting or servicing of products for customers and are not directly related to the core performance of Aetna’s
business operations. In addition, management uses operating earnings to assess business performance and to make decisions regarding its
operations and allocation of resources among its businesses.

Projected full year 2005 operating earnings and projected full year 2005 operating earnings per share for Aetna Inc. and Large Case Pensions
exclude the $43.4 million after tax reduction of reserves for anticipated future losses on discontinued products, included as an other item by the
Company for second quarter 2005. This represents a reduction of reserves previously established for certain products no longer offered by the
Company and does not benefit ongoing business operations.

Projected full year 2005 operating earnings and projected full year 2005 operating earnings per share for Aetna Inc. and the Health Care
segment exclude favorable development of prior period health care costs estimates of approximately $133 million pretax (approximately $84
million after tax), which were included in the results reported for first quarter 2005 and favorable development of prior period health care costs
estimates of approximately $55 million pretax (approximately $35 million after tax), which were included in the results reported for second
quarter 2005 and any further prior period reserve development. Projected operating earnings per share reflect the effect of the March 11, 2005
two-for-one stock split. Projected operating earnings per share for 2005 assume approximately 304 million weighted average diluted shares.
(2) Revenue excludes net realized capital gains or losses (pretax), which are included in reported GAAP revenue. Full year 2004 revenue of
$19.8 billion excludes net realized capital gains of $70.8 million; GAAP revenue was $19.9 billion. The projected full year 2005 revenue
excludes net realized capital gains (pretax) of $10.1 million reported by the Company for the six months ending June 30, 2005. The Company
cannot reconcile the projected 2005 revenue to GAAP revenue as it cannot project net realized capital gains or losses. The Company may from
time to time project revenue for the segments which cannot be reconciled for the same reasons.
(3) The operating expense ratio is calculated by dividing operating expenses by total revenue excluding net realized capital gains or losses. The
Company cannot reconcile the projected operating expense ratio to a comparable GAAP measure, as it cannot project net realized capital gains
or losses.
(4) Pretax operating margins are calculated by dividing pretax operating earnings, excluding net realized capital gains or losses, interest
expense and amortization of other acquired intangible assets by total revenue excluding net realized capital gains or losses. The projected
2005 pretax operating margin also excludes the favorable development of prior period health care cost estimates reported for first quarter and
second quarter 2005 (refer to Footnote 1) and any further prior period reserve development. The Company cannot reconcile the projected
pretax operating margins to a comparable GAAP measure, as it cannot project net realized capital gains or losses.
(5) Commercial Risk includes all medical and dental risk products except Medicare and Medicaid. Risk includes all medical and dental
products for which the Company assumes all or a majority of health care cost, utilization, or other risk.

(6) The projected 2005 MCR excludes the 2005 favorable development of prior period health care cost estimates reported for first quarter and
second quarter 2005 (refer to Footnote 1) and any further prior period reserve development, which the Company cannot project.

ADDITIONAL INFORMATION; CAUTIONARY STATEMENT - The 2005 information in this document is forward looking. Forward-
looking information is based on management's estimates, assumptions and projections, and is subject to significant uncertainties and other
factors, many of which are beyond Aetna's control. Important risk factors could cause actual future results and other future events to differ
materially from those currently estimated by management. Those risk factors include, but are not limited to: unanticipated increases in medical
costs (including increased medical utilization, increased pharmacy costs, increases resulting from unfavorable changes in contracting or re-
contracting with providers, changes in membership mix to lower-premium or higher-cost products or membership-adverse selection; as well as
changes in medical cost estimates due to the necessary extensive judgment that is used in the medical cost estimation process, the considerable
variability inherent in such estimates, and the sensitivity of such estimates to changes in medical claims payment patterns and changes in
medical cost trends); decreases in membership or failure to achieve desired membership growth due to significant competition or other factors;
increases in medical costs or Group Insurance claims resulting from any acts of terrorism or otherwise; the ability to reduce administrative
expenses while maintaining targeted levels of service and operating performance, and to improve relations with providers while taking actions


July 28, 2005                                                      Aetna Inc.                                                         Page 2 of 3
Aetna Inc.
to reduce medical costs; the ability to successfully implement Aetna's operating model to a projected growing membership base and to
successfully implement multiple strategic and operational initiatives simultaneously; lower levels of investment income from continued low
interest rates; adverse government regulation (including legislative proposals eliminating or reducing ERISA pre-emption of state laws that
would increase potential litigation exposure, and other proposals, such as patients' rights legislation, that would increase potential litigation
exposure or mandate coverage of certain health benefits); adverse pricing actions by government payors; changes in size, product mix and
medical cost experience of membership in key markets; our ability to integrate, simplify, and enhance our existing information technology
system and platform to keep pace with changing customer and regulatory needs; and the outcome of various litigation and regulatory matters,
including litigation and ongoing reviews of business practices by various regulatory authorities (including the current industry wide
investigation into insurance brokerage practices concerning broker compensation arrangements, bid quoting practices and potential antitrust
violations being conducted by the New York Attorney General, the Connecticut Attorney General, and others, and for which the Company has
received and may receive subpoenas, and may be subject to related litigation). For more discussion of important risk factors that may materially
affect Aetna, please see the risk factors contained in Aetna's 2004 Annual Report on Form 10-K, on file with the Securities and Exchange
Commission. You also should read Aetna's 2004 Annual Report on Form 10-K and Aetna's 2005 second quarter report on Form 10-Q when
filed with the Securities and Exchange Commission for a discussion of Aetna's historical results of operations and financial condition.


                                                                      ###




July 28, 2005                                                    Aetna Inc.                                                        Page 3 of 3

Weitere ähnliche Inhalte

Was ist angesagt?

AES 2006 Outlook
AES 2006 OutlookAES 2006 Outlook
AES 2006 Outlook
finance19
 
tenet healthcare Q208Slides_FINAL
tenet healthcare Q208Slides_FINALtenet healthcare Q208Slides_FINAL
tenet healthcare Q208Slides_FINAL
finance42
 
metlife Investor Day 2008 Finance
metlife 	Investor Day 2008 Financemetlife 	Investor Day 2008 Finance
metlife Investor Day 2008 Finance
finance5
 
Q3 fy15 earnings deck final
Q3 fy15 earnings deck finalQ3 fy15 earnings deck final
Q3 fy15 earnings deck final
Cardinal_Health
 
occidental petroleum Supplementals
occidental petroleum Supplementalsoccidental petroleum Supplementals
occidental petroleum Supplementals
finance13
 
Boeing News Release
Boeing  News Release Boeing  News Release
Boeing News Release
finance3
 
merck 3Q08 Earnings Release
merck  	3Q08 Earnings Release merck  	3Q08 Earnings Release
merck 3Q08 Earnings Release
finance11
 
ameriprise NR_042208_1
ameriprise NR_042208_1ameriprise NR_042208_1
ameriprise NR_042208_1
finance43
 
quest diagnostics 99annualreport
quest diagnostics 99annualreportquest diagnostics 99annualreport
quest diagnostics 99annualreport
finance34
 
Boom may '11 ir presentation
Boom may '11 ir presentationBoom may '11 ir presentation
Boom may '11 ir presentation
dynamicmaterials
 
Jefferies industrials conf. aug 11 small
Jefferies industrials conf. aug 11 smallJefferies industrials conf. aug 11 small
Jefferies industrials conf. aug 11 small
dynamicmaterials
 
tenet healthcare Q4_2007Conf_Call_D_13_FINAL_FINAL
tenet healthcare Q4_2007Conf_Call_D_13_FINAL_FINALtenet healthcare Q4_2007Conf_Call_D_13_FINAL_FINAL
tenet healthcare Q4_2007Conf_Call_D_13_FINAL_FINAL
finance42
 
Boom March 2011 IR Presentation
Boom March 2011 IR PresentationBoom March 2011 IR Presentation
Boom March 2011 IR Presentation
dynamicmaterials
 
pepsi bottling library.corporate
  	 pepsi bottling library.corporate  	 pepsi bottling library.corporate
pepsi bottling library.corporate
finance19
 
Trane First Quarter 2008 Earnings Conference Call
Trane First Quarter 2008 Earnings Conference Call  Trane First Quarter 2008 Earnings Conference Call
Trane First Quarter 2008 Earnings Conference Call
finance25
 
RYDERFINAL 3Q06Presentation
RYDERFINAL 3Q06PresentationRYDERFINAL 3Q06Presentation
RYDERFINAL 3Q06Presentation
finance44
 

Was ist angesagt? (16)

AES 2006 Outlook
AES 2006 OutlookAES 2006 Outlook
AES 2006 Outlook
 
tenet healthcare Q208Slides_FINAL
tenet healthcare Q208Slides_FINALtenet healthcare Q208Slides_FINAL
tenet healthcare Q208Slides_FINAL
 
metlife Investor Day 2008 Finance
metlife 	Investor Day 2008 Financemetlife 	Investor Day 2008 Finance
metlife Investor Day 2008 Finance
 
Q3 fy15 earnings deck final
Q3 fy15 earnings deck finalQ3 fy15 earnings deck final
Q3 fy15 earnings deck final
 
occidental petroleum Supplementals
occidental petroleum Supplementalsoccidental petroleum Supplementals
occidental petroleum Supplementals
 
Boeing News Release
Boeing  News Release Boeing  News Release
Boeing News Release
 
merck 3Q08 Earnings Release
merck  	3Q08 Earnings Release merck  	3Q08 Earnings Release
merck 3Q08 Earnings Release
 
ameriprise NR_042208_1
ameriprise NR_042208_1ameriprise NR_042208_1
ameriprise NR_042208_1
 
quest diagnostics 99annualreport
quest diagnostics 99annualreportquest diagnostics 99annualreport
quest diagnostics 99annualreport
 
Boom may '11 ir presentation
Boom may '11 ir presentationBoom may '11 ir presentation
Boom may '11 ir presentation
 
Jefferies industrials conf. aug 11 small
Jefferies industrials conf. aug 11 smallJefferies industrials conf. aug 11 small
Jefferies industrials conf. aug 11 small
 
tenet healthcare Q4_2007Conf_Call_D_13_FINAL_FINAL
tenet healthcare Q4_2007Conf_Call_D_13_FINAL_FINALtenet healthcare Q4_2007Conf_Call_D_13_FINAL_FINAL
tenet healthcare Q4_2007Conf_Call_D_13_FINAL_FINAL
 
Boom March 2011 IR Presentation
Boom March 2011 IR PresentationBoom March 2011 IR Presentation
Boom March 2011 IR Presentation
 
pepsi bottling library.corporate
  	 pepsi bottling library.corporate  	 pepsi bottling library.corporate
pepsi bottling library.corporate
 
Trane First Quarter 2008 Earnings Conference Call
Trane First Quarter 2008 Earnings Conference Call  Trane First Quarter 2008 Earnings Conference Call
Trane First Quarter 2008 Earnings Conference Call
 
RYDERFINAL 3Q06Presentation
RYDERFINAL 3Q06PresentationRYDERFINAL 3Q06Presentation
RYDERFINAL 3Q06Presentation
 

Ähnlich wie aetna Guidance Summary 2005 4th

aetna Guidance Summary 2008 2nd
aetna Guidance Summary 2008 2ndaetna Guidance Summary 2008 2nd
aetna Guidance Summary 2008 2nd
finance9
 
aetna Guidance Summary207 4th
aetna Guidance Summary207 4th aetna Guidance Summary207 4th
aetna Guidance Summary207 4th
finance9
 
aetna Guidance Summary 2008 3rd
aetna Guidance Summary 2008 3rdaetna Guidance Summary 2008 3rd
aetna Guidance Summary 2008 3rd
finance9
 
aetna Download Documentation Guidance Summary2007 3rd
aetna Download Documentation	Guidance Summary2007 3rdaetna Download Documentation	Guidance Summary2007 3rd
aetna Download Documentation Guidance Summary2007 3rd
finance9
 
Cardinal Health Q2 2009 Earnings Presentation
Cardinal Health Q2 2009 Earnings PresentationCardinal Health Q2 2009 Earnings Presentation
Cardinal Health Q2 2009 Earnings Presentation
finance2
 
goodrich 1Q08slides
goodrich  1Q08slidesgoodrich  1Q08slides
goodrich 1Q08slides
finance44
 
goodrich 1Q08slides
goodrich  1Q08slidesgoodrich  1Q08slides
goodrich 1Q08slides
finance44
 
arvinmeritor ARM_at_JPMorgan_Harbour_2007_FINAL
arvinmeritor ARM_at_JPMorgan_Harbour_2007_FINALarvinmeritor ARM_at_JPMorgan_Harbour_2007_FINAL
arvinmeritor ARM_at_JPMorgan_Harbour_2007_FINAL
finance27
 
merck 3Q08 Earnings Announcement
merck 3Q08 Earnings Announcementmerck 3Q08 Earnings Announcement
merck 3Q08 Earnings Announcement
finance11
 
Pfizer Quarterly Corporate Performance - First Quarter 2008
Pfizer Quarterly Corporate Performance - First Quarter 2008Pfizer Quarterly Corporate Performance - First Quarter 2008
Pfizer Quarterly Corporate Performance - First Quarter 2008
finance5
 
RYDERFINAL 3Q06Presentation
RYDERFINAL 3Q06PresentationRYDERFINAL 3Q06Presentation
RYDERFINAL 3Q06Presentation
finance44
 
RYDERFINAL Q406presentation
RYDERFINAL  Q406presentationRYDERFINAL  Q406presentation
RYDERFINAL Q406presentation
finance44
 
RYDERFINAL Q406presentation
RYDERFINAL Q406presentationRYDERFINAL Q406presentation
RYDERFINAL Q406presentation
finance44
 
aetna Earnings Release 2005 2nd
aetna Earnings Release 2005 2ndaetna Earnings Release 2005 2nd
aetna Earnings Release 2005 2nd
finance9
 
aon 1Q 08 Earnings Release
aon  1Q 08 Earnings Releaseaon  1Q 08 Earnings Release
aon 1Q 08 Earnings Release
finance27
 
806920110728
806920110728806920110728
806920110728
yo9889
 
RYDERFINAL Q407ryderearningsreport
RYDERFINAL Q407ryderearningsreportRYDERFINAL Q407ryderearningsreport
RYDERFINAL Q407ryderearningsreport
finance44
 

Ähnlich wie aetna Guidance Summary 2005 4th (20)

aetna Guidance Summary 2008 2nd
aetna Guidance Summary 2008 2ndaetna Guidance Summary 2008 2nd
aetna Guidance Summary 2008 2nd
 
aetna Guidance Summary207 4th
aetna Guidance Summary207 4th aetna Guidance Summary207 4th
aetna Guidance Summary207 4th
 
aetna Guidance Summary 2008 3rd
aetna Guidance Summary 2008 3rdaetna Guidance Summary 2008 3rd
aetna Guidance Summary 2008 3rd
 
aetna Download Documentation Guidance Summary2007 3rd
aetna Download Documentation	Guidance Summary2007 3rdaetna Download Documentation	Guidance Summary2007 3rd
aetna Download Documentation Guidance Summary2007 3rd
 
Cardinal Health Q2 2009 Earnings Presentation
Cardinal Health Q2 2009 Earnings PresentationCardinal Health Q2 2009 Earnings Presentation
Cardinal Health Q2 2009 Earnings Presentation
 
Monsanto Q3 2008 Financial Results
Monsanto Q3 2008 Financial ResultsMonsanto Q3 2008 Financial Results
Monsanto Q3 2008 Financial Results
 
goodrich 1Q08slides
goodrich  1Q08slidesgoodrich  1Q08slides
goodrich 1Q08slides
 
goodrich 1Q08slides
goodrich  1Q08slidesgoodrich  1Q08slides
goodrich 1Q08slides
 
arvinmeritor ARM_at_JPMorgan_Harbour_2007_FINAL
arvinmeritor ARM_at_JPMorgan_Harbour_2007_FINALarvinmeritor ARM_at_JPMorgan_Harbour_2007_FINAL
arvinmeritor ARM_at_JPMorgan_Harbour_2007_FINAL
 
merck 3Q08 Earnings Announcement
merck 3Q08 Earnings Announcementmerck 3Q08 Earnings Announcement
merck 3Q08 Earnings Announcement
 
Pfizer Quarterly Corporate Performance - First Quarter 2008
Pfizer Quarterly Corporate Performance - First Quarter 2008Pfizer Quarterly Corporate Performance - First Quarter 2008
Pfizer Quarterly Corporate Performance - First Quarter 2008
 
RYDERFINAL 3Q06Presentation
RYDERFINAL 3Q06PresentationRYDERFINAL 3Q06Presentation
RYDERFINAL 3Q06Presentation
 
RYDERFINAL Q406presentation
RYDERFINAL  Q406presentationRYDERFINAL  Q406presentation
RYDERFINAL Q406presentation
 
RYDERFINAL Q406presentation
RYDERFINAL Q406presentationRYDERFINAL Q406presentation
RYDERFINAL Q406presentation
 
aetna Earnings Release 2005 2nd
aetna Earnings Release 2005 2ndaetna Earnings Release 2005 2nd
aetna Earnings Release 2005 2nd
 
aon 1Q 08 Earnings Release
aon  1Q 08 Earnings Releaseaon  1Q 08 Earnings Release
aon 1Q 08 Earnings Release
 
3Q05FINAL
3Q05FINAL3Q05FINAL
3Q05FINAL
 
3Q05FINAL
3Q05FINAL3Q05FINAL
3Q05FINAL
 
806920110728
806920110728806920110728
806920110728
 
RYDERFINAL Q407ryderearningsreport
RYDERFINAL Q407ryderearningsreportRYDERFINAL Q407ryderearningsreport
RYDERFINAL Q407ryderearningsreport
 

Mehr von finance9

enterprise gp holdings Organizational and Ownership Structure Chart
enterprise gp holdings  Organizational and Ownership Structure Chart enterprise gp holdings  Organizational and Ownership Structure Chart
enterprise gp holdings Organizational and Ownership Structure Chart
finance9
 
enterprise gp holdings Standards of Business Conduct
enterprise gp holdings Standards of Business Conductenterprise gp holdings Standards of Business Conduct
enterprise gp holdings Standards of Business Conduct
finance9
 
enterprise gp holdings Governance Guidelines
enterprise gp holdings Governance Guidelinesenterprise gp holdings Governance Guidelines
enterprise gp holdings Governance Guidelines
finance9
 
enterprise gp holdings Audit, Conflicts & Governance Committee
enterprise gp holdings Audit, Conflicts & Governance Committeeenterprise gp holdings Audit, Conflicts & Governance Committee
enterprise gp holdings Audit, Conflicts & Governance Committee
finance9
 
enterprise gp holdings Code of Conduct & Related Policies
enterprise gp holdings Code of Conduct & Related Policiesenterprise gp holdings Code of Conduct & Related Policies
enterprise gp holdings Code of Conduct & Related Policies
finance9
 
02/11/09 HCA Announces Offering of $300 Million Senior Secured Second Lien Notes
02/11/09 HCA Announces Offering of $300 Million Senior Secured Second Lien Notes02/11/09 HCA Announces Offering of $300 Million Senior Secured Second Lien Notes
02/11/09 HCA Announces Offering of $300 Million Senior Secured Second Lien Notes
finance9
 
hca annual reports2000
hca annual reports2000hca annual reports2000
hca annual reports2000
finance9
 
hca annual reports2001
hca annual reports2001hca annual reports2001
hca annual reports2001
finance9
 
hca annual reports2002
hca annual reports2002hca annual reports2002
hca annual reports2002
finance9
 
hca annual reports2003
hca annual reports2003hca annual reports2003
hca annual reports2003
finance9
 
hca annual reports2004
hca annual reports2004hca annual reports2004
hca annual reports2004
finance9
 
hca annual reports2005
hca annual reports2005hca annual reports2005
hca annual reports2005
finance9
 
JP Morgan Presentation 15-Feb-2008
JP Morgan Presentation 15-Feb-2008JP Morgan Presentation 15-Feb-2008
JP Morgan Presentation 15-Feb-2008
finance9
 
HCA Presents at Bank of America 2008 Credit Conference 20-Nov-2008
HCA Presents at Bank of America 2008 Credit Conference 20-Nov-2008HCA Presents at Bank of America 2008 Credit Conference 20-Nov-2008
HCA Presents at Bank of America 2008 Credit Conference 20-Nov-2008
finance9
 
tyson foods 2007 Sustainability Report
tyson foods  2007 Sustainability Report tyson foods  2007 Sustainability Report
tyson foods 2007 Sustainability Report
finance9
 
tyson foods Investor Fact Book
tyson foods Investor Fact Book tyson foods Investor Fact Book
tyson foods Investor Fact Book
finance9
 
tyson foods 2008 Annual Report
tyson foods  2008 Annual Report tyson foods  2008 Annual Report
tyson foods 2008 Annual Report
finance9
 
general dynamics 2008 Proxy Statement
general dynamics 2008 Proxy Statement	 general dynamics 2008 Proxy Statement
general dynamics 2008 Proxy Statement
finance9
 
general dynamics 2007 Annual Report
general dynamics 2007 Annual Report	general dynamics 2007 Annual Report
general dynamics 2007 Annual Report
finance9
 
general dynamics Restated Certificate of Incorporation
general dynamics Restated Certificate of Incorporation general dynamics Restated Certificate of Incorporation
general dynamics Restated Certificate of Incorporation
finance9
 

Mehr von finance9 (20)

enterprise gp holdings Organizational and Ownership Structure Chart
enterprise gp holdings  Organizational and Ownership Structure Chart enterprise gp holdings  Organizational and Ownership Structure Chart
enterprise gp holdings Organizational and Ownership Structure Chart
 
enterprise gp holdings Standards of Business Conduct
enterprise gp holdings Standards of Business Conductenterprise gp holdings Standards of Business Conduct
enterprise gp holdings Standards of Business Conduct
 
enterprise gp holdings Governance Guidelines
enterprise gp holdings Governance Guidelinesenterprise gp holdings Governance Guidelines
enterprise gp holdings Governance Guidelines
 
enterprise gp holdings Audit, Conflicts & Governance Committee
enterprise gp holdings Audit, Conflicts & Governance Committeeenterprise gp holdings Audit, Conflicts & Governance Committee
enterprise gp holdings Audit, Conflicts & Governance Committee
 
enterprise gp holdings Code of Conduct & Related Policies
enterprise gp holdings Code of Conduct & Related Policiesenterprise gp holdings Code of Conduct & Related Policies
enterprise gp holdings Code of Conduct & Related Policies
 
02/11/09 HCA Announces Offering of $300 Million Senior Secured Second Lien Notes
02/11/09 HCA Announces Offering of $300 Million Senior Secured Second Lien Notes02/11/09 HCA Announces Offering of $300 Million Senior Secured Second Lien Notes
02/11/09 HCA Announces Offering of $300 Million Senior Secured Second Lien Notes
 
hca annual reports2000
hca annual reports2000hca annual reports2000
hca annual reports2000
 
hca annual reports2001
hca annual reports2001hca annual reports2001
hca annual reports2001
 
hca annual reports2002
hca annual reports2002hca annual reports2002
hca annual reports2002
 
hca annual reports2003
hca annual reports2003hca annual reports2003
hca annual reports2003
 
hca annual reports2004
hca annual reports2004hca annual reports2004
hca annual reports2004
 
hca annual reports2005
hca annual reports2005hca annual reports2005
hca annual reports2005
 
JP Morgan Presentation 15-Feb-2008
JP Morgan Presentation 15-Feb-2008JP Morgan Presentation 15-Feb-2008
JP Morgan Presentation 15-Feb-2008
 
HCA Presents at Bank of America 2008 Credit Conference 20-Nov-2008
HCA Presents at Bank of America 2008 Credit Conference 20-Nov-2008HCA Presents at Bank of America 2008 Credit Conference 20-Nov-2008
HCA Presents at Bank of America 2008 Credit Conference 20-Nov-2008
 
tyson foods 2007 Sustainability Report
tyson foods  2007 Sustainability Report tyson foods  2007 Sustainability Report
tyson foods 2007 Sustainability Report
 
tyson foods Investor Fact Book
tyson foods Investor Fact Book tyson foods Investor Fact Book
tyson foods Investor Fact Book
 
tyson foods 2008 Annual Report
tyson foods  2008 Annual Report tyson foods  2008 Annual Report
tyson foods 2008 Annual Report
 
general dynamics 2008 Proxy Statement
general dynamics 2008 Proxy Statement	 general dynamics 2008 Proxy Statement
general dynamics 2008 Proxy Statement
 
general dynamics 2007 Annual Report
general dynamics 2007 Annual Report	general dynamics 2007 Annual Report
general dynamics 2007 Annual Report
 
general dynamics Restated Certificate of Incorporation
general dynamics Restated Certificate of Incorporation general dynamics Restated Certificate of Incorporation
general dynamics Restated Certificate of Incorporation
 

Kürzlich hochgeladen

VIP Call Girl Service Andheri West ⚡ 9920725232 What It Takes To Be The Best ...
VIP Call Girl Service Andheri West ⚡ 9920725232 What It Takes To Be The Best ...VIP Call Girl Service Andheri West ⚡ 9920725232 What It Takes To Be The Best ...
VIP Call Girl Service Andheri West ⚡ 9920725232 What It Takes To Be The Best ...
dipikadinghjn ( Why You Choose Us? ) Escorts
 
VIP Independent Call Girls in Andheri 🌹 9920725232 ( Call Me ) Mumbai Escorts...
VIP Independent Call Girls in Andheri 🌹 9920725232 ( Call Me ) Mumbai Escorts...VIP Independent Call Girls in Andheri 🌹 9920725232 ( Call Me ) Mumbai Escorts...
VIP Independent Call Girls in Andheri 🌹 9920725232 ( Call Me ) Mumbai Escorts...
dipikadinghjn ( Why You Choose Us? ) Escorts
 
VIP Call Girl in Mira Road 💧 9920725232 ( Call Me ) Get A New Crush Everyday ...
VIP Call Girl in Mira Road 💧 9920725232 ( Call Me ) Get A New Crush Everyday ...VIP Call Girl in Mira Road 💧 9920725232 ( Call Me ) Get A New Crush Everyday ...
VIP Call Girl in Mira Road 💧 9920725232 ( Call Me ) Get A New Crush Everyday ...
dipikadinghjn ( Why You Choose Us? ) Escorts
 
CALL ON ➥8923113531 🔝Call Girls Gomti Nagar Lucknow best sexual service
CALL ON ➥8923113531 🔝Call Girls Gomti Nagar Lucknow best sexual serviceCALL ON ➥8923113531 🔝Call Girls Gomti Nagar Lucknow best sexual service
CALL ON ➥8923113531 🔝Call Girls Gomti Nagar Lucknow best sexual service
anilsa9823
 

Kürzlich hochgeladen (20)

VIP Call Girl Service Andheri West ⚡ 9920725232 What It Takes To Be The Best ...
VIP Call Girl Service Andheri West ⚡ 9920725232 What It Takes To Be The Best ...VIP Call Girl Service Andheri West ⚡ 9920725232 What It Takes To Be The Best ...
VIP Call Girl Service Andheri West ⚡ 9920725232 What It Takes To Be The Best ...
 
Booking open Available Pune Call Girls Wadgaon Sheri 6297143586 Call Hot Ind...
Booking open Available Pune Call Girls Wadgaon Sheri  6297143586 Call Hot Ind...Booking open Available Pune Call Girls Wadgaon Sheri  6297143586 Call Hot Ind...
Booking open Available Pune Call Girls Wadgaon Sheri 6297143586 Call Hot Ind...
 
VIP Independent Call Girls in Andheri 🌹 9920725232 ( Call Me ) Mumbai Escorts...
VIP Independent Call Girls in Andheri 🌹 9920725232 ( Call Me ) Mumbai Escorts...VIP Independent Call Girls in Andheri 🌹 9920725232 ( Call Me ) Mumbai Escorts...
VIP Independent Call Girls in Andheri 🌹 9920725232 ( Call Me ) Mumbai Escorts...
 
The Economic History of the U.S. Lecture 25.pdf
The Economic History of the U.S. Lecture 25.pdfThe Economic History of the U.S. Lecture 25.pdf
The Economic History of the U.S. Lecture 25.pdf
 
Indore Real Estate Market Trends Report.pdf
Indore Real Estate Market Trends Report.pdfIndore Real Estate Market Trends Report.pdf
Indore Real Estate Market Trends Report.pdf
 
Dharavi Russian callg Girls, { 09892124323 } || Call Girl In Mumbai ...
Dharavi Russian callg Girls, { 09892124323 } || Call Girl In Mumbai ...Dharavi Russian callg Girls, { 09892124323 } || Call Girl In Mumbai ...
Dharavi Russian callg Girls, { 09892124323 } || Call Girl In Mumbai ...
 
High Class Call Girls Nashik Maya 7001305949 Independent Escort Service Nashik
High Class Call Girls Nashik Maya 7001305949 Independent Escort Service NashikHigh Class Call Girls Nashik Maya 7001305949 Independent Escort Service Nashik
High Class Call Girls Nashik Maya 7001305949 Independent Escort Service Nashik
 
The Economic History of the U.S. Lecture 21.pdf
The Economic History of the U.S. Lecture 21.pdfThe Economic History of the U.S. Lecture 21.pdf
The Economic History of the U.S. Lecture 21.pdf
 
VIP Call Girl in Mira Road 💧 9920725232 ( Call Me ) Get A New Crush Everyday ...
VIP Call Girl in Mira Road 💧 9920725232 ( Call Me ) Get A New Crush Everyday ...VIP Call Girl in Mira Road 💧 9920725232 ( Call Me ) Get A New Crush Everyday ...
VIP Call Girl in Mira Road 💧 9920725232 ( Call Me ) Get A New Crush Everyday ...
 
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escorts
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur EscortsCall Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escorts
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escorts
 
(DIYA) Bhumkar Chowk Call Girls Just Call 7001035870 [ Cash on Delivery ] Pun...
(DIYA) Bhumkar Chowk Call Girls Just Call 7001035870 [ Cash on Delivery ] Pun...(DIYA) Bhumkar Chowk Call Girls Just Call 7001035870 [ Cash on Delivery ] Pun...
(DIYA) Bhumkar Chowk Call Girls Just Call 7001035870 [ Cash on Delivery ] Pun...
 
03_Emmanuel Ndiaye_Degroof Petercam.pptx
03_Emmanuel Ndiaye_Degroof Petercam.pptx03_Emmanuel Ndiaye_Degroof Petercam.pptx
03_Emmanuel Ndiaye_Degroof Petercam.pptx
 
06_Joeri Van Speybroek_Dell_MeetupDora&Cybersecurity.pdf
06_Joeri Van Speybroek_Dell_MeetupDora&Cybersecurity.pdf06_Joeri Van Speybroek_Dell_MeetupDora&Cybersecurity.pdf
06_Joeri Van Speybroek_Dell_MeetupDora&Cybersecurity.pdf
 
Solution Manual for Principles of Corporate Finance 14th Edition by Richard B...
Solution Manual for Principles of Corporate Finance 14th Edition by Richard B...Solution Manual for Principles of Corporate Finance 14th Edition by Richard B...
Solution Manual for Principles of Corporate Finance 14th Edition by Richard B...
 
Call Girls Koregaon Park Call Me 7737669865 Budget Friendly No Advance Booking
Call Girls Koregaon Park Call Me 7737669865 Budget Friendly No Advance BookingCall Girls Koregaon Park Call Me 7737669865 Budget Friendly No Advance Booking
Call Girls Koregaon Park Call Me 7737669865 Budget Friendly No Advance Booking
 
Top Rated Pune Call Girls Viman Nagar ⟟ 6297143586 ⟟ Call Me For Genuine Sex...
Top Rated  Pune Call Girls Viman Nagar ⟟ 6297143586 ⟟ Call Me For Genuine Sex...Top Rated  Pune Call Girls Viman Nagar ⟟ 6297143586 ⟟ Call Me For Genuine Sex...
Top Rated Pune Call Girls Viman Nagar ⟟ 6297143586 ⟟ Call Me For Genuine Sex...
 
CALL ON ➥8923113531 🔝Call Girls Gomti Nagar Lucknow best sexual service
CALL ON ➥8923113531 🔝Call Girls Gomti Nagar Lucknow best sexual serviceCALL ON ➥8923113531 🔝Call Girls Gomti Nagar Lucknow best sexual service
CALL ON ➥8923113531 🔝Call Girls Gomti Nagar Lucknow best sexual service
 
Best VIP Call Girls Noida Sector 18 Call Me: 8448380779
Best VIP Call Girls Noida Sector 18 Call Me: 8448380779Best VIP Call Girls Noida Sector 18 Call Me: 8448380779
Best VIP Call Girls Noida Sector 18 Call Me: 8448380779
 
(Vedika) Low Rate Call Girls in Pune Call Now 8250077686 Pune Escorts 24x7
(Vedika) Low Rate Call Girls in Pune Call Now 8250077686 Pune Escorts 24x7(Vedika) Low Rate Call Girls in Pune Call Now 8250077686 Pune Escorts 24x7
(Vedika) Low Rate Call Girls in Pune Call Now 8250077686 Pune Escorts 24x7
 
02_Fabio Colombo_Accenture_MeetupDora&Cybersecurity.pptx
02_Fabio Colombo_Accenture_MeetupDora&Cybersecurity.pptx02_Fabio Colombo_Accenture_MeetupDora&Cybersecurity.pptx
02_Fabio Colombo_Accenture_MeetupDora&Cybersecurity.pptx
 

aetna Guidance Summary 2005 4th

  • 1. Aetna Inc. The following is a summary of certain 2005 projected financial information and metrics provided on Aetna’s investor conference call on July 28, 2005. This information is provided for reference only, and has not been updated. You should consider the information to speak only as of its date of original publication. Aetna does not assume any responsibility to update the information to reflect subsequent events. Please also refer to the Cautionary Statement below for additional information regarding important risk factors that may affect the forward looking and other information. You should read this information in conjunction with Aetna’s earnings press release issued July 28, 2005 and should review the replay of the related investor call in full, since the press release provides further discussion of the Company’s results, and the investor call provides important context for the forward looking information. Aetna Inc. 2005 Guidance as of 7/28/2005 (Full year unless otherwise noted) Aetna Inc. Operating Earnings (1) $4.52 - $4.57 per share $1,375 - $1,390 million 3Q05 - $1.16 per share Revenue (excluding net realized capital gains or losses) (2) Greater than or equal to 13% Total Operating Expense Ratio (3) Slightly above 19% > Operating Earnings Operating Cash Flow Pretax Operating Margin (4) ≈ 10% ≈ 36% Effective Tax Rate ≈ $80 million Corporate Interest Expense Information by Segment: Health Care Operating Earnings (1) $1,305 - $1,320 million Growth 1,000k – 1,075k members Medical Membership Commercial Risk Cost Trend (5) 8.0% - 8.5% Commercial Risk MCR (5) (6) < 80% Commercial Risk Premium Yield (5) In line with cost trend Group Insurance Operating Earnings (1) ≈ $130 million LCP Operating Earnings (1) ≈ $20 million Note: The symbol “≈” means “approximately”. July 28, 2005 Aetna Inc. Page 1 of 3
  • 2. Aetna Inc. Footnotes (1) Projected 2005 operating earnings and projected 2005 operating earnings per share exclude the following after tax net realized capital gains (losses) reported by the Company for the six months ended June 30, 2005: Aetna Inc. $6.6 million; Health Care $3.8 million; Group Insurance $3.3 million and Large Case Pensions $(0.5) million and also exclude any future net realized capital gains or losses from income from continuing operations. The Company is not able to project the amount of future net realized capital gains or losses and cannot therefore reconcile projected 2005 operating earnings to projected income from continuing operations or reconcile to a projected change in income from continuing operations. Although the excluded items may recur, management believes that operating earnings and operating earnings per share provide a useful comparison of its underlying business performance from period to period. Net realized capital gains and losses arise from various types of transactions in the course of managing a portfolio of assets that support the payment of liabilities, but these transactions do not directly relate to the underwriting or servicing of products for customers and are not directly related to the core performance of Aetna’s business operations. In addition, management uses operating earnings to assess business performance and to make decisions regarding its operations and allocation of resources among its businesses. Projected full year 2005 operating earnings and projected full year 2005 operating earnings per share for Aetna Inc. and Large Case Pensions exclude the $43.4 million after tax reduction of reserves for anticipated future losses on discontinued products, included as an other item by the Company for second quarter 2005. This represents a reduction of reserves previously established for certain products no longer offered by the Company and does not benefit ongoing business operations. Projected full year 2005 operating earnings and projected full year 2005 operating earnings per share for Aetna Inc. and the Health Care segment exclude favorable development of prior period health care costs estimates of approximately $133 million pretax (approximately $84 million after tax), which were included in the results reported for first quarter 2005 and favorable development of prior period health care costs estimates of approximately $55 million pretax (approximately $35 million after tax), which were included in the results reported for second quarter 2005 and any further prior period reserve development. Projected operating earnings per share reflect the effect of the March 11, 2005 two-for-one stock split. Projected operating earnings per share for 2005 assume approximately 304 million weighted average diluted shares. (2) Revenue excludes net realized capital gains or losses (pretax), which are included in reported GAAP revenue. Full year 2004 revenue of $19.8 billion excludes net realized capital gains of $70.8 million; GAAP revenue was $19.9 billion. The projected full year 2005 revenue excludes net realized capital gains (pretax) of $10.1 million reported by the Company for the six months ending June 30, 2005. The Company cannot reconcile the projected 2005 revenue to GAAP revenue as it cannot project net realized capital gains or losses. The Company may from time to time project revenue for the segments which cannot be reconciled for the same reasons. (3) The operating expense ratio is calculated by dividing operating expenses by total revenue excluding net realized capital gains or losses. The Company cannot reconcile the projected operating expense ratio to a comparable GAAP measure, as it cannot project net realized capital gains or losses. (4) Pretax operating margins are calculated by dividing pretax operating earnings, excluding net realized capital gains or losses, interest expense and amortization of other acquired intangible assets by total revenue excluding net realized capital gains or losses. The projected 2005 pretax operating margin also excludes the favorable development of prior period health care cost estimates reported for first quarter and second quarter 2005 (refer to Footnote 1) and any further prior period reserve development. The Company cannot reconcile the projected pretax operating margins to a comparable GAAP measure, as it cannot project net realized capital gains or losses. (5) Commercial Risk includes all medical and dental risk products except Medicare and Medicaid. Risk includes all medical and dental products for which the Company assumes all or a majority of health care cost, utilization, or other risk. (6) The projected 2005 MCR excludes the 2005 favorable development of prior period health care cost estimates reported for first quarter and second quarter 2005 (refer to Footnote 1) and any further prior period reserve development, which the Company cannot project. ADDITIONAL INFORMATION; CAUTIONARY STATEMENT - The 2005 information in this document is forward looking. Forward- looking information is based on management's estimates, assumptions and projections, and is subject to significant uncertainties and other factors, many of which are beyond Aetna's control. Important risk factors could cause actual future results and other future events to differ materially from those currently estimated by management. Those risk factors include, but are not limited to: unanticipated increases in medical costs (including increased medical utilization, increased pharmacy costs, increases resulting from unfavorable changes in contracting or re- contracting with providers, changes in membership mix to lower-premium or higher-cost products or membership-adverse selection; as well as changes in medical cost estimates due to the necessary extensive judgment that is used in the medical cost estimation process, the considerable variability inherent in such estimates, and the sensitivity of such estimates to changes in medical claims payment patterns and changes in medical cost trends); decreases in membership or failure to achieve desired membership growth due to significant competition or other factors; increases in medical costs or Group Insurance claims resulting from any acts of terrorism or otherwise; the ability to reduce administrative expenses while maintaining targeted levels of service and operating performance, and to improve relations with providers while taking actions July 28, 2005 Aetna Inc. Page 2 of 3
  • 3. Aetna Inc. to reduce medical costs; the ability to successfully implement Aetna's operating model to a projected growing membership base and to successfully implement multiple strategic and operational initiatives simultaneously; lower levels of investment income from continued low interest rates; adverse government regulation (including legislative proposals eliminating or reducing ERISA pre-emption of state laws that would increase potential litigation exposure, and other proposals, such as patients' rights legislation, that would increase potential litigation exposure or mandate coverage of certain health benefits); adverse pricing actions by government payors; changes in size, product mix and medical cost experience of membership in key markets; our ability to integrate, simplify, and enhance our existing information technology system and platform to keep pace with changing customer and regulatory needs; and the outcome of various litigation and regulatory matters, including litigation and ongoing reviews of business practices by various regulatory authorities (including the current industry wide investigation into insurance brokerage practices concerning broker compensation arrangements, bid quoting practices and potential antitrust violations being conducted by the New York Attorney General, the Connecticut Attorney General, and others, and for which the Company has received and may receive subpoenas, and may be subject to related litigation). For more discussion of important risk factors that may materially affect Aetna, please see the risk factors contained in Aetna's 2004 Annual Report on Form 10-K, on file with the Securities and Exchange Commission. You also should read Aetna's 2004 Annual Report on Form 10-K and Aetna's 2005 second quarter report on Form 10-Q when filed with the Securities and Exchange Commission for a discussion of Aetna's historical results of operations and financial condition. ### July 28, 2005 Aetna Inc. Page 3 of 3